Skip to main content

Raiffeisen Bank International AG

Bank

Position in ALLO — Allogene Therapeutics, Inc.

CIK 2044885 VIENNA, C4

Position in ALLO

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$2,288,000
+$580,000 QoQ
Shares Held
1,100,000
+57.1% QoQ
Ownership
0.318%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#42
of 209 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALLO Over Time

Shares Held

Position Value (USD)

Derivatives in ALLO

reported options exposure · as of Jun 30, 2026
CallValue
$4,160
CallShares
2,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Raiffeisen Bank International AG holds $103,697,949 across 27 Biotechnology names. ALLO ranks #8 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 ALLO
Allogene Therapeutics, Inc.
This page
1,100,000 $2,288,000

All Filings in ALLO

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,288,000 1,100,000
2026-06-30 $4,160 2,000
2026-03-31 $4,880 2,000
2026-03-31 $1,708,000 700,000
2025-12-31 $2,740 2,000
2025-12-31 $1,233,000 900,000
2025-09-30 $2,480 2,000
2025-09-30 $558,000 450,000
2025-06-30 $454,260 402,000
2025-03-31 $586,920 402,000
2024-12-31 $915,900 430,000